NCT02568553 2025-11-26Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 1 Completed35 enrolled
NCT01075321 2020-10-22Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin LymphomaMayo ClinicPhase 1/2 Completed58 enrolled 12 charts
NCT01254578 2017-09-25Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancersNational Cancer Institute (NCI)Phase 1 Completed17 enrolled
NCT00031941 2012-03-15CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous TherapyNational Institutes of Health Clinical Center (CC)Phase 1 Completed